Funding awarded Collaborative genomic alterations and transcriptional control in prostate cancer awarded by National Cancer Institute Key Personnel 2019 - 2024
education and training Ph.D., Chinese Academy of Medical Sciences (China) 2018 M.S., Nankai University (China) 2015 B.S., Shanxi University (China) 2012